File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1136/gut.2010.231993
- Scopus: eid_2-s2.0-79958219307
- PMID: 21330577
- WOS: WOS:000291306900016
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: EZH2 protein: A promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies
Title | EZH2 protein: A promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies | ||||||||
---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||
Issue Date | 2011 | ||||||||
Publisher | BMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/ | ||||||||
Citation | Gut, 2011, v. 60 n. 7, p. 967-976 How to Cite? | ||||||||
Abstract | Background and aims: A previous study of ours indicated that enhancer of zeste homologue 2 (EZH2) plays an important role in hepatocellular carcinoma (HCC) tumorigenesis. The aim of the present study was to investigate the potential diagnostic utility of EZH2 in HCC. Methods: Immunohistochemistry was performed to examine the expression dynamics of EZH2 in two independent surgical cohorts of HCC and non-malignant liver tissues to develop a diagnostic yield of EZH2, HSP70 and GPC3 for HCC detection. The diagnostic performances of EZH2 and a three-marker panel in HCC were re-evaluated by using an additional biopsy cohort. Results: Immunohistochemistry analysis demonstrated that the sensitivity and specificity of EZH2 for HCC detection was 95.8% and 97.8% in the testing cohort. Similar results were confirmed in the validation cohort. For diagnosis of well-differentiated HCCs, the sensitivity and specificity were 68.9% and 91.5% for EZH2, 62.5% and 98.5% for HSP70, 50.0% and 92.1% for GPC3, and 75.0% and 100% for a three-marker panel. In biopsies, positive cases for at least one marker increased from large regenerative nodule and hepatocellular adenoma (0/12) to focal nodular hyperplasia (2/20), dysplastic nodule (7/25), well-differentiated HCC (16/18) and moderately and poorly differentiated HCC (54/54). When at least two positive markers were considered, regardless of their identity, the positive cases were detected in 0/12 large regenerative nodules and hepatocellular adenomas, 0/20 focal nodular hyperplasias, 0/25 dysplastic nodules, 11/18 well-differentiated HCCs, 32/37 moderately differentiated HCCs and 15/17 poorly differentiated HCCs. Conclusion: Our findings suggest that EZH2 protein, as examined by immunohistochemistry, may serve as a promising diagnostic biomarker of HCCs, and the use of a three-marker panel (EZH2, HSP70 and GPC3) can improve the rate of detection of HCCs in liver biopsy tissues. | ||||||||
Persistent Identifier | http://hdl.handle.net/10722/137272 | ||||||||
ISSN | 2023 Impact Factor: 23.0 2023 SCImago Journal Rankings: 8.052 | ||||||||
ISI Accession Number ID |
Funding Information: This study was supported by grants made under China's 973 National Basic Research Programme (Nos. 2010CB529401 and 2010CB912803) and 863 High Technology Development Programme (No. 2007AA021901), and by a grant from the Guangzhou Science and Technology Bureau Foundation (No. 2005Z1-E0131). | ||||||||
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cai, MY | en_HK |
dc.contributor.author | Tong, ZT | en_HK |
dc.contributor.author | Zheng, F | en_HK |
dc.contributor.author | Liao, YJ | en_HK |
dc.contributor.author | Wang, Y | en_HK |
dc.contributor.author | Rao, HL | en_HK |
dc.contributor.author | Chen, YC | en_HK |
dc.contributor.author | Wu, QL | en_HK |
dc.contributor.author | Liu, YH | en_HK |
dc.contributor.author | Guan, XY | en_HK |
dc.contributor.author | Lin, MC | en_HK |
dc.contributor.author | Zeng, YX | en_HK |
dc.contributor.author | Kung, HF | en_HK |
dc.contributor.author | Xie, D | en_HK |
dc.date.accessioned | 2011-08-26T14:22:15Z | - |
dc.date.available | 2011-08-26T14:22:15Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Gut, 2011, v. 60 n. 7, p. 967-976 | en_HK |
dc.identifier.issn | 0017-5749 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/137272 | - |
dc.description.abstract | Background and aims: A previous study of ours indicated that enhancer of zeste homologue 2 (EZH2) plays an important role in hepatocellular carcinoma (HCC) tumorigenesis. The aim of the present study was to investigate the potential diagnostic utility of EZH2 in HCC. Methods: Immunohistochemistry was performed to examine the expression dynamics of EZH2 in two independent surgical cohorts of HCC and non-malignant liver tissues to develop a diagnostic yield of EZH2, HSP70 and GPC3 for HCC detection. The diagnostic performances of EZH2 and a three-marker panel in HCC were re-evaluated by using an additional biopsy cohort. Results: Immunohistochemistry analysis demonstrated that the sensitivity and specificity of EZH2 for HCC detection was 95.8% and 97.8% in the testing cohort. Similar results were confirmed in the validation cohort. For diagnosis of well-differentiated HCCs, the sensitivity and specificity were 68.9% and 91.5% for EZH2, 62.5% and 98.5% for HSP70, 50.0% and 92.1% for GPC3, and 75.0% and 100% for a three-marker panel. In biopsies, positive cases for at least one marker increased from large regenerative nodule and hepatocellular adenoma (0/12) to focal nodular hyperplasia (2/20), dysplastic nodule (7/25), well-differentiated HCC (16/18) and moderately and poorly differentiated HCC (54/54). When at least two positive markers were considered, regardless of their identity, the positive cases were detected in 0/12 large regenerative nodules and hepatocellular adenomas, 0/20 focal nodular hyperplasias, 0/25 dysplastic nodules, 11/18 well-differentiated HCCs, 32/37 moderately differentiated HCCs and 15/17 poorly differentiated HCCs. Conclusion: Our findings suggest that EZH2 protein, as examined by immunohistochemistry, may serve as a promising diagnostic biomarker of HCCs, and the use of a three-marker panel (EZH2, HSP70 and GPC3) can improve the rate of detection of HCCs in liver biopsy tissues. | en_HK |
dc.language | eng | en_US |
dc.publisher | BMJ Publishing Group. The Journal's web site is located at http://gut.bmjjournals.com/ | en_HK |
dc.relation.ispartof | Gut | en_HK |
dc.rights | Gut. Copyright © BMJ Publishing Group. | - |
dc.subject.mesh | Carcinoma, Hepatocellular - diagnosis - pathology | - |
dc.subject.mesh | DNA-Binding Proteins - metabolism | - |
dc.subject.mesh | Liver Neoplasms - diagnosis - pathology | - |
dc.subject.mesh | Transcription Factors - metabolism | - |
dc.subject.mesh | Tumor Markers, Biological - metabolism | - |
dc.title | EZH2 protein: A promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Guan, XY:xyguan@hkucc.hku.hk | en_HK |
dc.identifier.email | Lin, MC:mcllin@hkucc.hku.hk | en_HK |
dc.identifier.authority | Guan, XY=rp00454 | en_HK |
dc.identifier.authority | Lin, MC=rp00746 | en_HK |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1136/gut.2010.231993 | en_HK |
dc.identifier.pmid | 21330577 | - |
dc.identifier.scopus | eid_2-s2.0-79958219307 | en_HK |
dc.identifier.hkuros | 190887 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-79958219307&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 60 | en_HK |
dc.identifier.issue | 7 | en_HK |
dc.identifier.spage | 967 | en_HK |
dc.identifier.epage | 976 | en_HK |
dc.identifier.isi | WOS:000291306900016 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Cai, MY=23388510500 | en_HK |
dc.identifier.scopusauthorid | Tong, ZT=36747652800 | en_HK |
dc.identifier.scopusauthorid | Zheng, F=39462354900 | en_HK |
dc.identifier.scopusauthorid | Liao, YJ=36114448500 | en_HK |
dc.identifier.scopusauthorid | Wang, Y=51161989600 | en_HK |
dc.identifier.scopusauthorid | Rao, HL=35277843000 | en_HK |
dc.identifier.scopusauthorid | Chen, YC=7601431852 | en_HK |
dc.identifier.scopusauthorid | Wu, QL=7404602639 | en_HK |
dc.identifier.scopusauthorid | Liu, YH=36014503900 | en_HK |
dc.identifier.scopusauthorid | Guan, XY=7201463221 | en_HK |
dc.identifier.scopusauthorid | Lin, MC=7404816359 | en_HK |
dc.identifier.scopusauthorid | Zeng, YX=7402981579 | en_HK |
dc.identifier.scopusauthorid | Kung, HF=7402514190 | en_HK |
dc.identifier.scopusauthorid | Xie, D=35070710200 | en_HK |
dc.identifier.issnl | 0017-5749 | - |